
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES179
An RCT288 comparing treatment with rosuvastatin 10 mg vs atorvastatin 10 mg, reported that at the end of the study rosuvastatin-treated patients had significantly lower LDL levels
compared with the atorvastatin group (p<0.0001). The study also reported that at 16 weeks, significantly more patients achieved their LDL goal with rosuvastatin compared with atorvastatin (94% vs 88%, p<0.05). Level 1+

[@Berne_2005]

